Associate Director, Clinical Quality Assurance (QA) – Redwood City, CA 94063

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As…
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks